Boston Scientific Operating Cash Flow — Historical Data
Boston Scientific (BSX) operating cash flow was $4.5B in FY2025 (+32% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$4.5B
+32%
2024
$3.4B
+37%
2023
$2.5B
+64%
2022
$1.5B
-18%
2021
$1.9B
+24%
2020
$1.5B
-18%
2019
$1.8B
+492%
2018
$310M
-78%
2017
$1.4B
+21%
2016
$1.2B
+71%
2015
$691M
-46%
2014
$1.3B
+14%
2013
$1.1B
-13%
2012
$1.3B
+27%
2011
$1.0B
+210%
2010
$325M
-61%
2009
$835M
-31%
2008
$1.2B
+30%
2007
$934M
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q2 2026
$1.5B
Q1 2026
$348M
Q4 2025
$1.4B
Q3 2025
$1.3B
Q2 2025
$1.3B
Q1 2025
$541M
Q4 2024
$1.5B
Q3 2024
$1.0B
Q2 2024
$813M
Q1 2024
$164M
Q4 2023
$957M
Q3 2023
$698M
Source: BSX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.